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Whether the number of organs available for transplant
would be positively or negatively affected by provid-
ing benefits to families of organ donors has been de-
bated by policymakers, ethicists and the transplant
community at large. We designed a telephone survey
to measure public opinion regarding the use of bene-
fits in general and of five types in particular: funeral
benefits, charitable contributions, travel/lodging ex-
penses, direct payments and medical expenses. Of the
971 adults who completed the survey (response rate =
69%), all were from Pennsylvania households, 45.6%
were registered organ donors, and 51.7% were non-
white. Although 59% of respondents favored the gen-
eral idea of incentives, support for specific incentives
ranged from 53% (direct payment) to 84% (medical ex-
penses). Among those registered as donors, more non-
whites than whites supported funeral benefits (88%
vs. 81%; p = 0.038), direct payment (63% vs. 41%;
p < 0.001) and medical expenses (92% vs. 84%; p =
0.013). Among those not registered as donors, more
nonwhites supported direct payment (64% vs. 46%;
p = 0.001). Most respondents believed that benefits
would not influence their own behavior concerning
donation but would influence the behavior of others.
While benefits appear to be favored, their true impact
can only be assessed through pilot programs.
Key words: Benefit programs, financial incentives,
organ donation
Received 10 January 2005, revised 4 August 2005 and
accepted for publication 5 August 2005
Introduction
The shortage of donor organs is well documented. As
transplant technology improves, more medical conditions
are treated through transplantation and, in turn, more peo-
ple are added to candidate waiting lists. Strides to increase
organ supply include technological advances (split or par-
tial organ transplants, artificial organs), use of living donors,
expansion of the donor criteria and educational programs
that encourage people to register as donors (1–4). Unfortu-
nately, these initiatives have been unable to close the gap
between need and supply.
Benefits or incentives for family members who consent
to donation are among the more controversial (and as yet
untested) strategies for increasing organ supply. Oppo-
nents argue that incentives are coercive to the poor and de-
humanize society by commodifying human bodies, while
proponents argue that individuals should be allowed to act
autonomously, consistent with their self-interests (5–9).
Even if one agrees that incentives are ethically acceptable,
the empirical question is whether they would increase do-
nation rates (10,11). Prior surveys report levels of support
ranging from 12% to 52% for incentive-based programs
(12–14). Some research indicates that incentives have the
potential to increase donations (15), whereas others con-
clude that incentives would not influence donation deci-
sions or that they would lead to possible backlash and the
falling of donation rates (12,14).
Part of the reason that findings are inconsistent is that
some studies ask about incentives generally while oth-
ers describe specific programs. The public tends to op-
pose “financial incentives” but to support directed bene-
fits, such as funeral expenses, life insurance or preferred
donor status (13,16–18). Methodological differences in
sampling frames also lead to differences. Previous polls
found greater support for benefits among respondents
who were younger, were nonwhite or had higher incomes
(13,19).
Prior studies have overlooked several pertinent issues.
They have not gauged opinion regarding the amount of
money that should be offered to families, nor have they
examined differences in the levels considered appropriate
based on ethnicity or income. These issues are particu-
larly important given disparities in transplant rates among
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minorities and given ethical concerns regarding exploita-
tion. Even in studies in which demographics have been
examined, support has not been assessed for a wide vari-
ety of benefits.
Our study was designed to survey a random sample of
Pennsylvania households about issues related to incen-
tives and benefits. We expected many households to
be knowledgeable about donor benefits because of two
events that occurred shortly before our survey took place.
First, the Pennsylvania Department of Health (in conjunc-
tion with the state’s organ procurement organizations) de-
veloped a pilot program to contribute $300 toward the fu-
neral expenses of each organ donor (20). This was the first
program in the United States allowing donors or their fam-
ilies to receive benefits, and it received substantial cover-
age from the news media (21–23). Second, the pilot pro-
gram was halted because of concerns that the provision of
funeral benefits violated federal law (24). Our decision to
focus on Pennsylvania residents was therefore motivated
both by the desire to explore the issues of incentives and
by the hope that our study might provide important insights
and enable the Department of Health to move forward with
its pilot program.
Our study explored whether respondents supported donor
benefits as a matter of policy and whether they thought
that benefits would affect donation rates. The study’s pri-
mary goal was to examine how public opinion varied with
the types of benefits offered and with the sociodemo-
graphic characteristics of respondents (particularly their
ethnicity and whether or not they were registered as
donors). The secondary goal was to collect information
about the amount of the incentive that respondents consid-
ered permissible and examine whether the amount varied
with types of benefits.
Methods
Between November 2000 and February 2001, we developed an 84-item
survey in conjunction with the Survey Research Program at the University
Center for Social and Urban Research. The survey was pre-tested (n = 24)
and modified. Between March 2001 and August 2001, we administered the
final version by telephone to a random sample of Pennsylvania households,
with oversampling of African American households. Unlike many surveys,
ours first asked about “incentives” generally and then inquired about spe-
cific types of benefits. Our study received approval from the University of
Pittsburgh Institutional Review Board.
Survey content
The focus of the survey was to describe several types of donor benefits and
ask respondents about providing such benefits to relatives of organ donors
through a state-run program.
First, we asked respondents whether they agreed or disagreed with the
following general statement: “The state should offer incentives or benefits
that encourage eligible families to donate a loved one’s organs.” Answers
were ranked on a five-point scale ranging from strongly agree to strongly
disagree (or were recorded as “does not know” or “refuses to answer”).
Second, we described five benefits that could potentially be offered to donor
families: funeral benefits for the organ donor, charitable contributions made
in the name of the organ donor, reimbursement of travel and lodging ex-
penses incurred by the family in conjunction with the organ donor’s death,
direct cash payments, and help with medical expenses incurred by the or-
gan donor. While these are not the only benefits that might be offered, we
chose them because they have been discussed in the literature and have
an inherent economic value. We randomized the order in which benefits
were presented to respondents. For each benefit, we asked the following:
(i) whether the respondent would favor or oppose a state program offering
such a benefit to eligible families; (ii) how the program would affect the
respondent’s own willingness to give consent and donate on behalf of a
family member; (iii) how the program would affect the respondent’s own
willingness to become (or remain) a registered organ donor and (iv) how the
respondent expected the program to affect the willingness of other people
to consent and donate organs on behalf of a family member.
Next, we asked respondents to estimate how much of a benefit (monetary
value) would be appropriate. We initially asked about a $300 funeral benefit,
to be consistent with Pennsylvania’s pilot program (“If the state went ahead
and offered a benefit, say funeral expenses, as a ‘thank you’ to families
who donated, do you think that an amount of $300 is too little, too much
or approximately the right amount to offer?”). If respondents did not agree
with the $300 value, we asked them to specify an amount they considered
appropriate. Likewise, we asked if all types of benefits should have the same
value. If not, we again asked respondents to specify suitable amounts for
the other benefits.
The survey also included general attitudinal questions about organ trans-
plantation and donation based on prior work by two of our investigators
(25). We asked knowledge-based questions about Pennsylvania’s pilot pro-
gram and collected demographic data, including information about gender,
age, race, education, religion, occupation and income. Finally, we recorded
whether the respondent was a registered organ donor and whether he or
she personally knew anyone involved in the transplantation process (e.g.
candidates, recipients, donors, donor families).
Sampling frame and sample size calculations
Pennsylvania residents who were 18 years or older, spoke English and lived
in residential households with a telephone were eligible for our survey. A
random sample of households provided by a commercial sampling firm
served as our final sampling frame. Using census data on the proportion of
African American households, we mapped each three-digit telephone ex-
change into “high-density” and “low-density” areas, and we oversampled
from high-density areas. To compute a 95% confidence interval around the
estimated approval rating (i.e. the proportion of households in favor of ben-
efits) with 4% precision, we needed a total of 925 respondents, including
at least 385 African Americans.
When interviewers contacted a household, they asked to interview the
head of the family. If unavailable, they asked to speak with any available
household member over 18 years old.
Statistical analysis
We examined the proportion of respondents who knew of Pennsylvania’s
proposed funeral benefits program and determined how they learned of
the program (e.g. newspapers, television, friends). We then asked about
other potential donor programs. Because we wanted to know whether
support differed depending on whether we used generic terminology
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(“incentives”) or described specific programs, we first computed the per-
centage of respondents who favored the general idea of a state-sponsored
benefit program. We then computed the level of support for the five pro-
grams considered in the survey. Next, we examined the likely impact of
benefits on respondents’ own willingness to donate organs of a family
member, respondents’ own willingness to register as an organ donor and
respondents’ beliefs about the willingness of other people to donate organs
of a family member.
We were interested in the effect of respondent characteristics, especially
current donor status (to test whether incentives might decrease donation
rates among registered donors) and ethnicity (to address concerns that in-
centive programs target minority donors). Because these covariates are
not independent (chi square = 49.6, p = 0.001), we used proportional
z-tests to determine if there were differences in the proportion of favor-
able responses by ethnicity within donor status categories.
In multivariable analyses, we included ethnicity, donor status and their in-
teraction as covariates. We additionally adjusted for age, gender, education
(college graduate or not), household income, religion (Christianity, Judaism,
other, none), whether the respondent knew someone involved in the trans-
plant process and whether the respondent ever worked in a health-related
setting. To estimate overall support for donor benefits, we used logistic
regression and defined the outcome as “in favor” or “not in favor.” For
the “willingness” questions, which have three possible outcomes (“more
willing,” “no effect” and “less willing”), we used multinomial logistic re-
gression. For brevity, we discuss findings from the multivariable analyses
but do not provide coefficient estimates (available by request). Analyses
were completed using SAS (Cary, NC).
Finally, we summarized data regarding the appropriate monetary value of
donor benefits. When asked to provide specific amounts, respondents an-
swered in variable ways, with some stating exact dollar amounts and oth-
ers providing ranges or giving qualitative responses (e.g. “it depends on
the family’s needs,” “no amount is too much to offer”). We therefore fo-
cused our analysis on questions specific to the proposed value of $300 and
examined whether respondents considered this to be too little, too much
or approximately the right amount to offer. We used chi square tests to
determine if there were differences based on donor status and ethnicity.
Results
Sociodemographic characteristics
The survey was completed by 971 respondents (Table 1),
representing 69% of the eligible households we contacted.
The average age of respondents was 44 years (range:
18–91 years). Most (65%) were female, and 41% were
African American (including 9 persons of mixed ethnicity).
More than 30% graduated from college, and 56% reported
household incomes of $30 000 or more.
Of the respondents, 45.6% (n = 443) said they had a signed
organ donor card or a donor designation on their driver’s li-
cense. This percentage is slightly higher than the statewide
average of 42.3% (26). Donor status varied by ethnicity,
with 57% of white respondents and 35% of nonwhite
respondents indicating that they were registered donors.
Half of the respondents (n = 479) said they personally
knew someone involved in the organ transplantation pro-
cess, and one-third (n = 340) worked at some point in a
health-related occupation or setting.
Table 1: Characteristics of study respondents
Study
respondents
Characteristics (n = 971)





Other race/ethnicity 9.1 (16.7)
Refused to answer 1.2 (16.7)
College graduate (%) 30.8 (16.7)






Do not know, refused to answer 1.2 (16.7)
Registered organ donor (%) 45.6 (16.7)
Personally knew someone involved 49.3 (16.7)
in the transplant process (%)†
Worked in a health-related 35.0 (16.7)
occupation or setting (%)
∗SD indicates standard deviation.
†Based on personally knowing any of the following: a transplant
candidate, a transplant recipient, an organ donor or a family
member who was asked to consent and donate the organs of a
loved one.
Of the 80 respondents (8.2%) who said they heard of a
benefits program in Pennsylvania, only 13 (1.3% of the
total sample) recalled specific details about the program
(data not shown). Ten (1.0%) learned about the program
through the media. In comparison with our overall sample,
this group was slightly younger (mean age: 41.5 years;
range: 24–60 years), and 9 (0.9%) worked in healthcare
settings.
Overall findings
We found moderate support for donor benefits as a general
policy, with 59% of respondents agreeing that “the state
should offer incentives or benefits that encourage eligible
families to donate a loved one’s organs.”
As shown in Table 2, level of support was substantially
higher when we asked specifically about funeral benefits,
charitable contributions, travel/lodging expenses and med-
ical expenses (which were supported by 81%, 73%, 78%
and 84% of respondents, respectively), and it was lower
when we asked specifically about direct payment (which
was supported by only 53% of respondents).
When we asked respondents how specific benefit pro-
grams would affect their own willingness to donate organs
on behalf of a family member, between 71% and 76% (de-
pending on the benefit) said that benefits would have no
effect. Among those for whom a benefit would have an
impact, most reported that the benefit would make them
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Table 2: Respondents’ reaction to donor benefits
Percentage indicating Percentage indicating Percentage who anticipated
Overall support an effect on own an effect on own an effect on
for benefits willingness to willingness to willingness of others
programs (%)∗ consent/donate† register as a donor† to donate‡
Type of benefit Favor Oppose More likely Less likely More likely Less likely More likely Less likely
Funeral benefits 81 17 23 3 22 5 68 5
Charitable contributions 73 25 21 5 18 8 51 8
Travel/lodging expenses 78 19 22 2 20 4 64 5
Direct payment 53 42 17 8 16 9 59 5
Medical expenses 84 13 26 3 24 5 70 4
∗Percentage who did not know or refused to answer is not shown (range: 2–5%).
†Percentage reporting no effect, did not know or refused to answer is not shown (range: 71–76%).
‡Percentage reporting no effect, did not know or refused to answer is not shown (range: 26–41%).
more willing to donate. Net gains in willingness (defined
as the percentage that would be “more willing” minus
the percentage that would be “less willing”) were positive
for all five benefits but were largest for medical expenses
(23%) and smallest for direct payment (9%).
When we asked respondents how specific benefits would
affect their own willingness to register as an organ donor if
they were not currently registered or to remain registered
if they were currently registered, from 71% to 76% (de-
pending on benefit) again said that donor benefits would
have no effect (Table 2). Net gains in willingness were again
positive for all five benefits but were largest for medical ex-
penses (19%) and smallest for direct payment (7%).
Unlike the expectation that they themselves would be un-
affected, when we asked respondents to predict the effect
of donor benefits on other people’s actions, most believed
that donor benefits would encourage others to donate or-
gans (Table 2). The respondents predicted that net gains in
other people’s willingness to donate would be positive for
all five benefits but would be largest for medical expenses
(66%) and smallest for charitable contributions (43%).
When we asked respondents whether a benefit worth
$300 was too little, too much or approximately the right
amount, many were uncertain (Figure 1). The proportion
who were unsure or refused to answer ranged from 3%
(n = 33, funeral benefits) to 14% (n = 137, medical ex-
penses). Of the remainder, most believed that $300 was
too little. The majority of respondents who believed that
$300 was too much were those who opposed benefits
entirely.
Support for benefits based on donor
status and ethnicity
We found no evidence to suggest that the group of respon-
dents who were registered as organ donors (group 1) were
more opposed to benefit programs as a general policy than
the group of respondents who were not registered as or-
gan donors (group 2). On the contrary, group 1 was highly
committed to the organ donation process and showed a
level of support that was equal to or greater than that of
group 2 (results available by request). Only direct payment,
which received the lowest level of support in both groups,
was significantly less popular in group 1 (50% vs. 56%,
p = 0.004). Within each group, however, overall support for
specific benefits varied by ethnicity, with greater support
from nonwhite respondents. As shown in Table 3, ethnicity-
related differences were significant for the three benefits
(funeral benefits, direct payment and medical expenses)
among respondents in group 1 and were significant for the
one benefit (direct payment) among respondents in group
2. In the adjusted models, nonwhite respondents were still
twice as likely to support direct payment as white respon-
dents.
With respect to their own decisions, results by donor sta-
tus and ethnicity did not differ substantially from our overall
findings. When asked how specific benefits would affect
their own willingness to donate organs on behalf of a family
member, the only significant difference between group 1
and group 2 was that group 1 appeared more supportive of
direct payment. Within group 1, there were no differences
between white and nonwhite respondents (Table 4). Within
group 2, support for charitable contributions and medi-
cal expenses was higher among whites than nonwhites
(Table 4). In multivariable analyses, group 1 remained
more supportive of direct payments than did group 2, and
support for charitable contributions remained significantly
higher in whites than in nonwhites.
When we asked respondents how specific benefits would
affect their group membership, we found that the propor-
tion who were already in group 1 and were willing to remain
there (i.e. continue being registered donors) was higher
than the proportion who were currently in group 2 and
were willing to join group 1 (i.e. become registered donors).
This finding persisted in the multinomial regressions after
adjusting for other covariates. Within group 1, nonwhite
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Figure 1: Appropriateness of a $300 benefit. For all of the proposed benefits, most respondents felt that $300 was too little to offer
donor families. Sample sizes varied across benefits because we excluded respondents who either did not know or refused to answer.
We also excluded 12 respondents who did not provide race information.
donors demonstrated more willingness to remain regis-
tered than white donors, but the difference was only sig-
nificant for funeral benefits and medical expenses (Table 5).
Within group 2, net gains in willingness to become regis-
tered ranged from 0% to 21% across benefits, with no
significant differences by ethnicity (Table 5).
When we asked respondents to predict the effect of donor
benefits on other people’s actions, we found that those in
group 1 anticipated higher net gains than those in group
2 (Table 6). Overall, those who were in group 2 and were
nonwhite predicted the smallest net gains across all types
of benefits.
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Table 3: Respondents’ overall support for specific benefits, by ethnicity within donor status∗
Percentage in favor of benefit program
Registered as organ donor Not registered as organ donor
Total sample White Nonwhite White Nonwhite
Type of benefit (n = 971) (n = 268) (n = 169) p-values (n = 201) (n = 321) p-values
Funeral benefits 81 81 88 0.038 77 80 0.397
Charitable contributions 73 76 78 0.738 71 68 0.438
Travel/lodging expenses 78 75 79 0.345 75 81 0.133
Direct payment 53 41 63 < 0.001 46 64 0.001
Medical expenses 84 84 92 0.013 84 81 0.420
∗Respondents were divided into two groups based on their donor status. Proportional z-tests were used to compare differences in the
responses of whites and nonwhites within each group. The 12 respondents who refused to provide race information are not included in
the results.
Table 4: Net effect of benefits on respondents’ willingness to donate organs of a loved one, by ethnicity within donor status∗
Net percentage† who would be more willing to provide consent and donate
Registered as organ donor Not registered as organ donor
Total sample White Nonwhite White Nonwhite
Type of benefit (n = 971) (n = 268) (n = 169) p-values (n = 201) (n = 321) p-values
Funeral benefits 20 21 21 0.966 20 19 0.747
Charitable contributions 16 19 15 0.361 19 10 0.049
Travel/lodging expenses 20 20 22 0.755 20 17 0.461
Direct payment 9 10 16 0.157 4 9 0.301
Medical expenses 23 24 26 0.761 28 16 0.007
∗The p-value indicates the significance level of white versus nonwhite, within donor status using a proportional z-test. A total of 12
respondents refused to provide race information.
†Net percentage = (percentage “more willing”) – (percentage “less willing”).
Table 5: Net effect of benefits on respondents’ willingness to become (or remain) a registered organ donor, by ethnicity within donor
status∗
Net percentage† who would be more willing to sign/renew a donor card
Registered as organ donor Not registered as organ donor
Total sample White Nonwhite White Nonwhite
Type of benefit (n = 971) (n = 268) (n = 169) p-values (n = 201) (n = 321) p-values
Funeral benefits 17 16 26 0.026 18 12 0.164
Charitable contributions 10 16 15 0.880 11 3 0.093
Travel/lodging expenses 16 16 22 0.104 17 13 0.366
Direct payment 7 9 14 0.267 0 7 0.183
Medical expenses 19 18 28 0.012 21 15 0.212
∗The p-value indicates the significance level of white versus nonwhite, within donor status using a proportional z-test. A total of 12
respondents refused to provide race information.
†Net percentage = (percentage “more willing”) – (percentage “less willing”).
When we asked respondents about the appropriateness
of a $300 benefit, trends for white and nonwhite respon-
dents (Figure 2) were similar to those in the overall sample
(Figure 1), but white respondents were more likely to rate
$300 as appropriate and also more likely to oppose bene-
fits of any kind, whereas the nonwhite respondents were
more likely to view $300 as too little (p = 0.001 for each
benefit).
Discussion
There are several concerns regarding the generalizability
of our findings. First, because Pennsylvania has several
large transplant hospitals and two organ procurement or-
ganizations actively involved in educational programs, res-
idents might be more receptive than the general pop-
ulation to efforts promoting organ donation. The media
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Table 6: Net perceived effect of benefits on others’ willingness to donate organs of a loved one, by ethnicity within donor status∗
Net percentage† who said others would be more willing to consent and donate
Registered as organ donor Not registered as organ donor
Total sample White Nonwhite White Nonwhite
Type of benefit (n = 971) (n = 268) (n = 169) p-values (n = 201) (n = 321) p-values
Funeral benefits 63 68 72 0.453 67 53 0.010
Charitable contributions 43 49 38 0.073 46 38 0.156
Travel/lodging expenses 59 68 60 0.114 69 45 0.001
Direct payment 64 70 70 0.993 68 56 0.032
Medical expenses 66 71 73 0.670 75 55 0.001
∗The p-value indicates the significance level of white versus nonwhite, within donor status using a proportional z-test. A total of 12
respondents refused to provide race information.
†Net percentage = (percentage “more willing”) – (percentage “less willing”).
coverage when Pennsylvania’s pilot program was pro-
posed (and again when it was canceled) might also affect
respondents’ receptiveness, but the fact that only 1% of
our sample demonstrated any familiarity with details of
the program suggests that this was not the case. Sec-
ond, the proportion of respondents who indicated that they
were registered organ donors (45.6%) may appear to be
high, but it is indeed similar to the statewide estimate for
adults over 18 years old (42.3%) (26). The proportion of
respondents who reported knowing someone involved in
the transplantation process (49.3%) was also high, and un-
fortunately there is no statewide estimate to use for com-
parison. Third, as with other surveys, ours can be criticized
on the grounds that the data cannot be verified and that
self-reported beliefs may differ from actual behavior when
confronted with a donation decision (18).
Despite these limitations, our study offers several useful
insights. Unlike earlier studies, we framed the issue of in-
centives in a manner that allowed respondents to explore
and express their beliefs from a number of angles. It asked
respondents to consider the concept of incentives in terms
of the general idea and specific examples of the idea. It
also asked them to consider the effects of incentives on
their own actions and on the actions of others. All of these
considerations come into play both in individual decision
making and in public policymaking.
Most respondents favored the idea of providing donor ben-
efits as a matter of policy and also believed that bene-
fits would have a positive effect on overall organ donation
rates. At the same time, however, respondents generally
believed that their own decisions regarding donation would
not be influenced by the offer of benefits. Beliefs about the
appropriate value for donor benefits were less clear, but vir-
tually no one, in favor of donor benefits, felt that an initial
program offering $300 was inappropriate.
Concerns that the offer of benefits would have differ-
ent effects based on donor status or ethnicity of re-
spondents were not substantiated in our study, since
the similarities between groups generally outweighed
the differences. We did not find that currently regis-
tered donors would oppose benefits and reconsider their
decision to donate, thereby leading to an overall de-
crease in the supply of transplantable organs. On the
contrary, registered donors appeared highly committed to
their donation decision and expressed strong support for
benefit programs. The number of respondents opposed
to benefits was small, and most were not registered
donors.
Within the group of respondents who were already regis-
tered as organ donors, nonwhite respondents were more
positive about donor benefits as a general concept, but
whites and nonwhites held similar beliefs about how the
offer of benefits would affect their own actions and the
actions of others. Within the group of respondents who
were not registered as organ donors, whites were more
optimistic that donor benefits would increase overall do-
nation rates. In general, nonwhite respondents were more
likely to consider a $300 benefit to be too little.
Although our findings suggest that donor benefits hold
promise, they also suggest that direct payment is not
the place to start. Of the five types of benefits included
in our survey (funeral benefits, charitable contributions,
travel/lodging expenses, direct payment and medical ex-
penses), direct payment received the lowest level of sup-
port both in the overall survey sample and when the sam-
ple was stratified according to respondents’ donor status.
Moreover, direct payment was the most polarizing type of
benefit, resulting in the largest differences between eth-
nic groups. For efforts to be effective and to avoid ethical
concerns about targeting minorities, our data suggest that
offering one of the other types of benefits might be a more
useful place to start.
Unfortunately, the first opportunity to systematically eval-
uate the effects of donor benefits on donation rates was
lost when the Pennsylvania Department of Health canceled
its pilot program before the U.S. Department of Justice
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Figure 2: Appropriateness of a $300 benefit, by ethnicity. Nonwhite respondents were more likely to consider $300 to be “too little”
for donor benefits, while white respondents were more likely to oppose any payment at all (p-value = 0.001 for all benefits). Sample
sizes varied across benefits because we excluded respondents who either did not know or refused to answer. We also excluded 12
respondents who did not provide race information.
could issue an opinion about its compliance with federal
law (24,27,28). Funds that were earmarked for the pilot pro-
gram have been used to offset donation-related travel and
lodging expenses. Most requests for such reimbursement
have come from living donors and not families of deceased
donors (27). National support for similar programs was ap-
proved in the U.S. House of Representatives in 2003 (29)
and in both the House and Senate in 2004 (30), and sev-
eral state laws provide tax deductions for living donors up
to $10 000 as well (31–33).
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Because federal law allows for remuneration for expenses
incurred as part of the donation process, these programs
for living donors are viewed as “reimbursements” rather
than as “incentives.” In contrast, programs for deceased
donors or their families continue to face opposition and
have yet to marshal the support needed to successfully
navigate the political process. However, lack of Congres-
sional action for broader exploration of donor benefits does
not mean that they are not a viable option. The American
Medical Association’s Council on Ethical and Judicial Affairs
(34,35) supports pilot programs to evaluate donor bene-
fits, and the Organ Donation and Recovery Improvement
Act provides that “the Secretary of Health and Human Ser-
vices, in consultation with appropriate entities, including
advocacy groups representing those populations that are
likely to be disproportionately affected by proposals to in-
crease cadaveric donation, shall submit to the appropriate
committees of Congress a report that evaluates the ethi-
cal implications of such proposals” (30). In response, the
Institute of Medicine is currently working with a panel of
experts to study various options for increasing organ dona-
tion rates, including the use of financial incentives for both
living and deceased donors (36).
We believe that the results of our study are policy-relevant
and suggest that donor benefit programs offer one viable
option for improving donation rates. We hope that our find-
ings will provide the impetus needed both to inform policy
and to encourage studies to test the effects of donor ben-
efits for all types of donors.
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